Plasma Metabolic and Inflammatory Protein Signatures in Psychiatric Disorders
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136260 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Manel Naifar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Laboratory "Molecular Basis of Human Diseases", LR19ES13, Sfax Medicine College, University of Sfax, Sfax 3029, Tunisia. Hauptthemen laut MEDLINE: Bipolar Disorder, Schizophrenia, Psychotic Disorders, Mental Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psychiatric disorders, particularly schizophrenia (SCZ), bipolar disorder (BD), and schizoaffective disorder (SAD), present significant diagnostic challenges. Current diagnostic methods rely on clinical observation and self-reported symptoms, leading to under-diagnosis and delayed treatment. To address this gap, we applied mass spectrometry-based metabolomic profiling and targeted analysis of inflammatory proteins to plasma samples from patients versus controls, aiming to uncover disease-related molecular patterns and enhance our understanding of the underlying pathophysiology of these complex disorders. This study included 26 patients with BD, 34 with SCZ, 16 with SAD, and age- and sex-matched controls. All diagnoses were established according to DSM-5 criteria. Unsupervised analysis shows a clear separation between controls and patients, indicating distinct metabolic and inflammatory profiles. However, the lack of clear differentiation among the three disease subgroups suggests shared biological profiles across these psychiatric disorders. Biomolecules driving this separation between controls and patients includes decreased levels of proinflammatory cytokines, amino acids, and glycerophospholipids, and increased levels of acylcarnitines. This study represents a step towards addressing the limitations of current diagnostic approaches to severe psychiatric disorders, which rely heavily on clinical symptoms, by using omics approaches to refine their diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Laboratory "Molecular Basis of Human Diseases", LR19ES13, Sfax Medicine College, University of Sfax, Sfax 3029, Tunisia.
- UNIROUEN, AIMS, CHU Rouen, Reference Center for Lysosomal Diseases, Filière Maladies Héréditaires du Métabolisme (G2M), Department of Metabolic Biochemistry, Normandie University, F-76000 Rouen, France.
- Psychiatry C-Department, Hedi Chaker University Hospital, University of Sfax, Sfax 3029, Tunisia.
ORCID-Profile: Manel Naifar, Wassim Guidara, Soumeya Bekri
Zitieren
APA
Naifar, M., Ducatez, F., Guidara, W., Maalej, M., Lesueur, C., Pilon, C., Plichet, T., Maalej, M., Ayadi, F., & Bekri, S. (2025). Plasma Metabolic and Inflammatory Protein Signatures in Psychiatric Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136260
Vancouver
Naifar M, Ducatez F, Guidara W, Maalej M, Lesueur C, Pilon C, et al. Plasma Metabolic and Inflammatory Protein Signatures in Psychiatric Disorders. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136260
BibTeX
@article{Naifar2025,
author = {Naifar, Manel and Ducatez, Franklin and Guidara, Wassim and Maalej, Manel and Lesueur, Celine and Pilon, Carine and Plichet, Thomas and Maalej, Mohamed and Ayadi, Fatma and Bekri, Soumeya},
title = {Plasma Metabolic and Inflammatory Protein Signatures in Psychiatric Disorders},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136260}
}
EUVIMED